The IBI Insulin Biosimilars Information Study Group brand, founded in 2010 (France), from 2757 sister brands and 17478 competing brands. IBI Insulin Biosimilars Information Study Group is a brand of SANOFI, listed on the stock exchange of Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. IBI Insulin Biosimilars Information Study Group belongs to the Drug Manufacturers business sector.